Acceso abierto

Maternal and neonatal outcomes among women with and without severe acute respiratory syndrome corona virus-2 infection: A retrospective analytical study

Pratyasha Peepal
Pratyasha Peepal
, 
Tanushree Sandipta Rath
Tanushree Sandipta Rath
, 
Saurav Nayak
Saurav Nayak
 y 
Sujata Pendyala
Sujata Pendyala
   | 01 abr 2022
Journal of Mother and Child's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Article Category: Original research
Publicado en línea: 01 abr 2022
Páginas: 77 - 85
Recibido: 29 ago 2021
Aceptado: 17 nov 2021
DOI: https://doi.org/10.34763/jmotherandchild.20212502.d-21-00021
Palabras clave
© 2021 Pratyasha Peepal et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.

Fig. 1

Incidence of COVID-19 infection in pregnancy
Incidence of COVID-19 infection in pregnancy

Fig. 2

Comparison of parity of women in the study population
Comparison of parity of women in the study population

Fig. 3

Mode of delivery
Mode of delivery

Fig. 4

Neonatal outcomes in babies born to both groups of women
Neonatal outcomes in babies born to both groups of women

Fig. 5

Indications of NICU admission
Indications of NICU admission

Fig. 6(a)

Comparison of APGAR scores at 1minute (COVID-19 Positive live birth =87 COVID-19 Negative live birth = 202)
Comparison of APGAR scores at 1minute (COVID-19 Positive live birth =87 COVID-19 Negative live birth = 202)

Fig. 6(b)

Comparison of APGAR scores at 5 minutes (COVID-19 Positive live birth =87 COVID-19 Negative live birth = 202)
Comparison of APGAR scores at 5 minutes (COVID-19 Positive live birth =87 COVID-19 Negative live birth = 202)

Comparison of birth weights in both the groups of women

Birth Weight (In Kg) Covid-19 positive n (%) Covid-19 negative n (%) Total p value
>3.5 20(21.73) 19(9.00) 39 0.001
3-3.4 28(30.43) 53(25.11) 81
2.5-2.9 28(30.43) 67(31.75) 95
2-2.4 3(3.26) 41(19.43) 44
1.5-1.9 6(6.52) 17(8.05) 23
<1.5 7(7.60) 14(6.63) 21
TOTAL 92 211 303

Maternal co-morbidities and complications

PARAMETERS Covid-19 positive n (%) Covid-19 negative n (%) p value
1.Hypothyroidism 6 (6.52) 37 (17.53) 0.012
2.GDM/Type 2 DM 2 (2.17) 9 (4.26) 0.514
3.PIH 2 (2.17) 16 (7.58) 0.069
4.PPROM/PROM 9(9.78) 28(13.27) 0.450
5.APLA Syndrome 0(0) 4(1.89) 0.318
6.Rh negative pregnancy 2(0) 5(2.36) 1.000
7placentae) .APH(placenta previa/abruption 0(0) 5(2.36) 0.328
8anaemia/.Hemoglobinopathies(Thalassemia) Sickle cell 0(0) 2(0.94) 1.000
9.Cholestasis of pregnancy 0(0) 3(1.42) 0.556
10.Anaemia(Hemoglobin<11gm/dl) 48(52.17) 75(35.54) 0.001

Gestational age at delivery

Gestational Age (In Weeks) Covid-19 positive n (%) Covid-19 negative n (%) Total p value
<34 9 (9.78) 18 (8.53) 27 0.427
34-36.6 7(7.60) 30(14.21) 37
37-41.6 74(80.43) 163(77.25) 237
>42 2(2.17) 0(0.00) 2
TOTAL 92 211 303

Age-wise distribution of patients in COVID-19 positive and negative groups

Age (Years) Covid-19 positive n(%) Covid-19 negative n(%) Total p value
<=20 9 (9.78) 1 (0.47) 10 <0.001
21-25 21(22.82) 36(17.06) 57
26-35 36(39.13) 96(45.49) 132
>35 26(28.26) 78(36.96) 104
TOTAL 92 211 303

Indications of LSCS performed in the study population

Indication COVID-19 positive n (%) COVID-19 negative n (%) p-Value
Previous LSCS 18(19.56) 42(19.90) 0.540
Fetal distress 12(13) 20(9.47) 0.231
Elective LSCS 14(15.21) 10(4.73) 0.002
Oligohydramnios 3(3.26) 6(2.84) 0.549
Breech presentation 1(1.08) 7(3.31) 0.443
Multiple pregnancy 3(3.26) 7(3.31) 1.000
IUGR 0(0) 8(3.79) 0.111
APH 0(0) 5(2.36) 0.328
Doppler USG changes in 0(0) 2(0.94) 1.000
eISSN:
2719-535X
Idioma:
Inglés
Calendario de la edición:
Volume Open
Temas de la revista:
Medicine, Clinical Medicine, Pediatrics and Juvenile Medicine, Paediatric Haematology and Oncology, Public Health
RSS Feed de revista